AngioDynamics
ANGO
135 hedge funds and large institutions have $305M invested in AngioDynamics in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 44 reducing their positions, and 25 closing their positions.
1,056% more call options, than puts
Call options by funds: $2.58M | Put options by funds: $223K
21% more capital invested
Capital invested by funds: $251M → $305M (+$53.5M)
20% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 44
2.38% more ownership
Funds ownership: 79.48% → 81.86% (+2.4%)
2% less funds holding
Funds holding: 138 → 135 (-3)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.74M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$4.65M |
| 3 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$3.78M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$3.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$3.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
-$7.78M |
| 2 |
BlackRock
New York
|
-$5.29M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$2.39M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.55M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$1.46M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
151
Teza Capital Management
Chicago,
Illinois
| – | -$104K | -13,351 | Closed |
|
152
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| – | -$85.6K | -11,000 | Closed |
|
|
BFM
153
Boothbay Fund Management
New York
| – | -$85.2K | -10,952 | Closed |
|
|
QL
154
Quarry LP
New York
| – | -$66.3K | -8,518 | Closed |
|
155
Allspring Global Investments
Charlotte,
North Carolina
| – | -$49.4K | -6,349 | Closed |
|
|
CFM
156
Catalyst Funds Management
Sydney NSW,
Australia
| – | -$48K | -6,166 | Closed |
|
|
CPA
157
Capital Performance Advisors
Walnut Creek,
California
| – | -$8.6K | -1,105 | Closed |
|
|
TWD
158
True Wealth Design
Akron,
Ohio
| – | -$5.07K | -651 | Closed |
|
|
S
159
SignatureFD
Atlanta,
Georgia
| – | -$4.68K | -602 | Closed |
|
|
CFG
160
CKW Financial Group
Honolulu,
Hawaii
| – | -$125 | -17 | Closed |
|
ANGO Hedge Fund Activity: Q4 2024 in Review
135 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2024, worth a combined $305M — up 21% from $251M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ANGO and 22 opened new positions — a net loss of 3 holders — while 44 trimmed existing stakes and 53 added.
The largest buyer was UBS Group, adding an estimated $6.74M. The largest seller was Kent Lake PR, exiting entirely with an estimated $7.78M sold.
- 135 institutional investors held AngioDynamics (ANGO) as of Q4 2024, down from 138 in Q3 2024.
- Funds reported $305M of AngioDynamics stock for Q4 2024, up 21% quarter-over-quarter.
- 22 funds opened new AngioDynamics positions in Q4 2024 and 25 closed out, a net change of -3 holders.
- The largest AngioDynamics buyer in Q4 2024 was UBS Group, an estimated $6.74M added.
- The largest AngioDynamics seller in Q4 2024 was Kent Lake PR, an estimated $7.78M sold.
Based on aggregated 13F filings for Q4 2024.